Trial Details
TERMINATEDBasic Information
| Clinical ID | c4651 |
|---|---|
| Identifier | NCT00206661 |
| Trial Title | Safety and Efficacy Study in the Treatment of Pediatric Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Sargramostim (Leukine)|DRUG: Sargramostim (Leukine) |
Participant Information
| Sponsor | Genzyme, a Sanofi Company |
|---|---|
| City | San Francisco |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2004-12 |
|---|---|
| Primary Completion Date | 2006-12 |
| Completion Date | 2006-12 |